Azithromycin contraindications: Difference between revisions

Jump to navigation Jump to search
mNo edit summary
mNo edit summary
 
(3 intermediate revisions by the same user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Azithromycin}}
{{CMG}}
==Contraindications==
ZITHROMAX is contraindicated in patients with known hypersensitivity to [[azithromycin]], [[erythromycin]], any [[macrolide]] or [[ketolide]] antibiotic. Zithromax is contraindicated in patients with a history of [[cholestatic jaundice]]/[[hepatic dysfunction]] associated with prior use of azithromycin.<ref>{{Cite web | last = | first =|title =http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/050710s039,050711s036,050784s023lbl.pdf | url =http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/050710s039,050711s036,050784s023lbl.pdf | publisher = |date = | accessdate = }}</ref>
==References==
{{Reflist}}
{{FDA}}
[[Category:Antibiotics]]
[[Category:Wikinfect]]

Latest revision as of 21:43, 5 January 2014

Azithromycin
ZITHROMAX® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Clinical Studies
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Contraindications

ZITHROMAX is contraindicated in patients with known hypersensitivity to azithromycin, erythromycin, any macrolide or ketolide antibiotic. Zithromax is contraindicated in patients with a history of cholestatic jaundice/hepatic dysfunction associated with prior use of azithromycin.[1]

References

  1. "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/050710s039,050711s036,050784s023lbl.pdf" (PDF). External link in |title= (help)

Adapted from the FDA Package Insert.